Globus Medical Income Statement
GMED / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Globus Medical reported $2.9B in revenue and $538M in net income for FY2025. Revenue has grown at a 16.9% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 3.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.9B | $2.5B | $1.6B | $1.0B | $785.4M | $713.0M | $785.4M | $713.0M | $636.0M | $564.0M | $544.8M | $474.4M | $434.5M | $386.0M | $331.5M |
| Cost of Revenue | $957.8M | $1.0B | $548.2M | $263.7M | $180.0M | $159.4M | $180.0M | $159.4M | $150.5M | $134.7M | $132.3M | $110.8M | $100.3M | $75.2M | $68.8M |
| Gross Profit | - | - | $1.0B | $759.1M | $605.4M | $553.6M | $605.4M | $553.6M | $485.5M | $429.3M | $412.4M | $363.6M | $334.1M | $310.8M | $262.7M |
| SG&A Expense | $1.2B | $981.4M | $643.8M | $432.1M | $354.8M | $311.6M | $354.8M | $311.6M | $267.8M | $222.2M | $210.2M | $188.6M | $182.5M | $168.9M | $140.4M |
| R&D Expense | $147.2M | $163.8M | $124.0M | $73.0M | $60.1M | $55.5M | $60.1M | $55.5M | $43.7M | $44.5M | $36.3M | $31.2M | $26.9M | $27.9M | $23.5M |
| Operating Income | $479.8M | $166.0M | $133.1M | $228.0M | $172.0M | $169.3M | $172.0M | $169.3M | $161.8M | $154.1M | $172.2M | $138.4M | $101.7M | $114.8M | $97.4M |
| Interest Expense | - | -$4.2M | $20.1M | $14.2M | $17.4M | $13.3M | $17.4M | $13.3M | $6.6M | $3.1M | $1.3M | $805.0K | $467.0K | $80.0K | - |
| Income Tax | $67.2M | $17.7M | $42.5M | $52.9M | $34.7M | $32.1M | $34.7M | $32.1M | $62.6M | $52.9M | $60.0M | $46.2M | $33.4M | $40.8M | $36.2M |
| Net Income | $537.9M | $103.0M | $122.9M | $190.2M | $155.2M | $156.5M | $155.2M | $156.5M | $107.3M | $104.3M | $112.8M | $92.5M | $68.6M | $73.8M | $60.8M |
| EPS (Basic) | $3.98 | $0.76 | $1.09 | $1.89 | $1.57 | $1.60 | $1.57 | $1.60 | $1.12 | $1.09 | $1.19 | $0.98 | $0.74 | $0.82 | $0.69 |
| EPS (Diluted) | $3.92 | $0.75 | $1.07 | $1.85 | $1.52 | $1.54 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 | $0.73 | $0.80 | $0.67 |
| Shares Outstanding | 137.1M | 137.9M | 114.6M | 102.6M | 102.0M | 101.3M | 99.8M | 98.6M | 96.7M | 95.9M | 95.3M | 94.7M | 93.4M | 91.3M | 90.4M |
| Gross Margin | - | - | 65.0% | 74.2% | 77.1% | 77.6% | 77.1% | 77.6% | 76.3% | 76.1% | 75.7% | 76.6% | 76.9% | 80.5% | 79.2% |
| Operating Margin | 16.3% | 6.6% | 8.5% | 22.3% | 21.9% | 23.8% | 21.9% | 23.8% | 25.4% | 27.3% | 31.6% | 29.2% | 23.4% | 29.7% | 29.4% |
| Profit Margin | 18.3% | 4.1% | 7.8% | 18.6% | 19.8% | 21.9% | 19.8% | 21.9% | 16.9% | 18.5% | 20.7% | 19.5% | 15.8% | 19.1% | 18.3% |